Literature DB >> 6689564

Acute proliferative retrolental fibroplasia: multivariate risk analysis.

J T Flynn.   

Abstract

This study has presented a two-way analysis of a data set consisting of demographic, diagnostic, and therapeutic variables against the risk of occurrence of APRLF and its location in the retina in a population of 639 infants in birthweights ranging from 600 to 1500 gm. Univariate and multivariate risk analysis techniques were employed to analyze the data. As established from previous studies, birthweight was a powerful predictor of the outcome variable. Oxygen therapy as defined and quantified in this study was not. Duration of ventilatory assistance did seem associated. The population was not uniform. Infants below 1000 gm birthweight had such a high incidence of APRLF that no other exogenous risk factors seemed of significance. Above 1000 gm birthweight, certain factors, particularly duration of ventilation, seemed of predictive strength and significance.

Entities:  

Mesh:

Year:  1983        PMID: 6689564      PMCID: PMC1312463     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  44 in total

1.  The possibility of total elimination of retrolental fibroplasia by oxygen restriction.

Authors:  L P GUY; J T LANMAN; J DANCIS
Journal:  Pediatrics       Date:  1956-02       Impact factor: 7.124

2.  Retrolental fibroplasia.

Authors:  L P GUY; J DANCIS; J T LANMAN
Journal:  N Y State J Med       Date:  1953-12-15

3.  CLASSIFICATION of retrolental fibroplasia.

Authors: 
Journal:  Am J Ophthalmol       Date:  1953-10       Impact factor: 5.258

4.  Neurological and Ophthalmic Disorders in Children of Very Low Birth Weight.

Authors:  A D McDonald
Journal:  Br Med J       Date:  1962-03-31

5.  Estimation of the probability of an event as a function of several independent variables.

Authors:  S H Walker; D B Duncan
Journal:  Biometrika       Date:  1967-06       Impact factor: 2.445

6.  Congenital retrolental fibroplasia.

Authors:  R C Karlsberg; W R Green; A Patz
Journal:  Arch Ophthalmol       Date:  1973-02

7.  Nonhyperoxic retrolental fibroplasia.

Authors:  D H Adamkin; R J Shott; L N Cook; B F Andrews
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

8.  Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.

Authors:  H M Hittner; L B Godio; A J Rudolph; J M Adams; J A Garcia-Prats; Z Friedman; J A Kautz; W A Monaco
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245

9.  Retrolental fibroplasia--controlled study of 4 years' experience in a neonatal intensive care unit.

Authors:  V Y Yu; D M Hookham; J R Nave
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  13 in total

1.  Onset of retinopathy of prematurity as related to postnatal and postconceptional age.

Authors:  G E Quinn; L Johnson; S Abbasi
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

2.  An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice.

Authors:  C Klaeger; L de Sa; A J Klaeger; E J Carlson; W V Good; C J Epstein
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

3.  A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity.

Authors:  J T Flynn; E Bancalari; E S Snyder; R N Goldberg; W Feuer; J Cassady; J Schiffman; H I Feldman; B Bachynski; E Buckley
Journal:  Trans Am Ophthalmol Soc       Date:  1991

4.  Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach.

Authors:  Chengjian Tu; Kay D Beharry; Xiaomeng Shen; Jun Li; Lianshui Wang; Jacob V Aranda; Jun Qu
Journal:  J Proteome Res       Date:  2015-04-06       Impact factor: 4.466

5.  Clinical factors associated with retinopathy of prematurity.

Authors:  A Prendiville; W E Schulenburg
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

6.  Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity.

Authors:  Luz Consuelo Zepeda-Romero; Miguel Vazquez-Membrillo; Elva Adan-Castro; Francisco Gomez-Aguayo; Jose Alfonso Gutierrez-Padilla; Eusebio Angulo-Castellanos; Juan Carlos Barrera de Leon; Cesareo Gonzalez-Bernal; Manuel Alejandro Quezada-Chalita; Alonso Meza-Anguiano; Nundehui Diaz-Lezama; Gonzalo Martinez de la Escalera; Jakob Triebel; Carmen Clapp
Journal:  Pediatr Res       Date:  2016-11-14       Impact factor: 3.756

7.  The apparent role of blood transfusions in the development of retinopathy of prematurity.

Authors:  R W Cooke; D Clark; M Hickey-Dwyer; A M Weindling
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

8.  A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity.

Authors:  Kenneth W Wright; David Sami; Lisa Thompson; Rangasamy Ramanathan; Roy Joseph; Sonal Farzavandi
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 9.  IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Authors:  Raffael Liegl; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Early Hum Dev       Date:  2016-09-17       Impact factor: 2.079

10.  Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study.

Authors:  Birgit Lorenz; Katerina Spasovska; Heike Elflein; Nico Schneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-22       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.